Skip to main content
. Author manuscript; available in PMC: 2012 Sep 24.
Published in final edited form as: Epidemiology. 2011 Jul;22(4):589–597. doi: 10.1097/EDE.0b013e3182117c85

Table 5.

Results of simulations assessing main/internal validation study-based analysis under case-control samplinga,b

Non-differential Case: SE1 = SP1 = SE0= SP0 = 0.8
Model β^1 (SD) 95% CI coverage β^2 (SD) 95% CI coverage
“Naïve” 0.30 (0.06) 0.0% 0.07 (0.16) 22.7%
Main/internal validationb 2.04 (0.20) 95.3% 0.51 (0.27) 95.1%
Differential Case: SE1=0.8, SP1=0.7, SE0=0.6, SP0=0.9
Model β^1 (SD) 95% CI coverage β^2 (SD) 95% CI coverage
“Naïve” 0.30 (0.07) 0.0% 1.28 (0.16) 0.0%
Main/internal validationb 2.02 (0.20) 95.2% −0.07 (0.30) 48.0%
a

1000 simulations in each case; 500 internal validation and roughly 1,000 main study observations per simulation based on 100% and 5% sampling of cases and controls, respectively. True model (1) parameters: (β01β2) = (−0.4, 2.0, 0.5)

b

Main/internal validation study likelihood defined in Eq. (7)(8)